INCB099280, Adagrasib
INCB 99280-204
Phase 2 small_molecule active
Quick answer
INCB099280, Adagrasib for Advanced Solid Tumors Harboring a KRASG12C Mutation is a Phase 2 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Advanced Solid Tumors Harboring a KRASG12C Mutation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active